MOS
PTLA

MGO One Seven’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

MGO One Seven’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-150
Closed -$2K – 1873
2018
Q4 		$2K Buy
+150
New +$3.08K ﹤0.01% 1635

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

MGO One Seven's PTLA Position: Q1 2019 in Review

MGO One Seven sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2019, closing a stake of 150 shares — an estimated $2K sold.

MGO One Seven first reported a position in PTLA in Q4 2018 and held it in 1 quarter. The position peaked at $2K in Q4 2018. 209 funds tracked by Wall St. Rank hold PTLA as of Q1 2019.

  • MGO One Seven reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
  • MGO One Seven sold 150 Portola Pharmaceuticals, Inc. shares in Q1 2019, an estimated $2K.
  • MGO One Seven first reported a position in Portola Pharmaceuticals, Inc. in Q4 2018 and held it in 1 quarter.
  • MGO One Seven's Portola Pharmaceuticals, Inc. position peaked at $2K in Q4 2018.
  • 209 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2019.

Based on MGO One Seven's 13F filing for Q1 2019, filed 9 Apr 2019.